{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:15:57Z","timestamp":1792671357576,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bioorg.2021.105331","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:39:47Z","timestamp":1630708787000},"page":"105331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Assessment of elementary derivatives of 1,5-benzodiazepine as anticancer agents with synergy potential"],"prefix":"10.1016","volume":"117","author":[{"given":"Sinthiya J.","family":"Gawandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya G.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinivas","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Shingade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuvir R.","family":"Pissurlenkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bioorg.2021.105331_b0005","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/10408398.2016.1263597","article-title":"Synthesis, Characterization and Evaluation of Anticancer Activity of Nanoresveratrol in B16 Melanoma Cell Line","volume":"58","author":"Rauf","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105331_b0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/pon.4601","article-title":"Predictors of emotional distress a year or more after diagnosis of cancer: A systematic review of the literature","volume":"27","author":"Cook","year":"2018","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.bioorg.2021.105331_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2018.05.008","article-title":"Perspectives on the past, present, and future of cancer nanomedicine","volume":"130","author":"Youn","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2021.105331_b0020","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2021.105331_b0025","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cell.2017.11.009","article-title":"Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy","volume":"171","author":"Palmer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2021.105331_b0030","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/s41467-020-16735-2","article-title":"A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities","volume":"11","author":"Narayan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2021.105331_b0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs","volume":"328","author":"Sugahara","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2021.105331_b0040","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2021.105331_b0045","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.1254721","article-title":"Patient-derived models of acquired resistance can identify effective drug combinations for cancer","volume":"346","author":"Crystal","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2021.105331_b0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7150\/ijms.1.101","article-title":"Tyrosine kinase \u2013 Role and significance in Cancer","volume":"1","author":"Paul","year":"2004","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bioorg.2021.105331_b0055","first-page":"3491","article-title":"Receptor Tyrosine Kinase-Targeted Cancer Therapy","volume":"19","author":"Yamaoka","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bioorg.2021.105331_b0060","doi-asserted-by":"crossref","unstructured":"Charles Pottier, Margaux Fresnais, Marie Gilon, Guy J\u00e9rusalem, R\u00e9mi Longuesp\u00e9e, Nor Eddine Sounni, Review: Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy. Cancers 12 (2020) 1-17. 731.","DOI":"10.3390\/cancers12030731"},{"key":"10.1016\/j.bioorg.2021.105331_b0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2019.06.054","article-title":"Yi Jin, Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole\/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase","volume":"179","author":"Yuan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejmech.2017.12.022","article-title":"Discovery of anilinofuro[2,3-d]pyrimidine derivatives as dual inhibitors of EGFR\/HER2 tyrosine kinase and their anticancer activity","volume":"144","author":"Hossam","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0075","series-title":"Waller C","first-page":"235","author":"Rawluk","year":"2018"},{"key":"10.1016\/j.bioorg.2021.105331_b0080","first-page":"1","article-title":"Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells","volume":"217","author":"Tanaka","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioorg.2021.105331_b0085","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/cncr.31346","article-title":"Glisson, Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial","volume":"124","author":"Gold","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2021.105331_b0090","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s13402-020-00566-w","article-title":"Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy \u2013 potential clinical relevance","volume":"43","author":"D\u2019Amore","year":"2020","journal-title":"Cellular Oncol."},{"key":"10.1016\/j.bioorg.2021.105331_b0095","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejphar.2016.08.004","article-title":"Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines","volume":"789","author":"Yang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105331_b0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2017.08.037","article-title":"Pharmacological synergism of 2,2-dichloroacetophenone and EGFR-TKi to overcome TKi-induced resistance in NSCLC cells","volume":"815","author":"Yang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105331_b0105","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3390\/cancers12092586","article-title":"Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer","volume":"12","author":"Wen","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2021.105331_b0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fchem.2019.00509","article-title":"Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data","volume":"7","author":"Sidorov","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cis-platin nephrotoxicity: A review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"Journal of Nephrology"},{"key":"10.1016\/j.bioorg.2021.105331_b0120","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/ijms18081733","article-title":"Taxol: The first microtubule stabilizing agent","volume":"18","author":"Yang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2021.105331_b0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2021.01.026","article-title":"Inhibition of DHFR targets the self-renewing potential of brain tumor initiating cells","volume":"503","author":"Fawal","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2021.105331_b0130","doi-asserted-by":"crossref","unstructured":"M. Raimondi, O. Randazzo, M. Franca, G. Barone, E. Vignoni, D. Rossi, S. Collina, DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents 24(6) (2019) 1140.","DOI":"10.3390\/molecules24061140"},{"key":"10.1016\/j.bioorg.2021.105331_b0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0190-9622(03)00803-X","article-title":"Methotrexate and psoriasis in the era of new biologic agents","volume":"50","author":"Saporito","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioorg.2021.105331_b0140","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/rheumatology\/36.11.1196","article-title":"The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases","volume":"36","author":"Furst","year":"1997","journal-title":"British J. Rheumatol."},{"key":"10.1016\/j.bioorg.2021.105331_b0145","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1073\/pnas.77.10.5663","article-title":"5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates","volume":"77","author":"Fernandes","year":"1980","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2021.105331_b0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ibd.20000","article-title":"Synergistic effect of methotrexate and infliximab on activated lymphocyte apoptosis","volume":"13","author":"Brande","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bioorg.2021.105331_b0155","first-page":"16","article-title":"Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro","volume":"2002","author":"Akutsu","year":"1808","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2021.105331_b0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0920-1211(89)90065-X","article-title":"A comparison of the anticonvulsant effects of 1, 4-and 1, 5-benzodiazepines in the amygdala-kindled rat and their effects on motor function","volume":"3","author":"Tietz","year":"1989","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bioorg.2021.105331_b0165","doi-asserted-by":"crossref","first-page":"10774","DOI":"10.1128\/JVI.01253-16","article-title":"A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein","volume":"90","author":"Guo","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2021.105331_b0170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/cbdd.12739","article-title":"Efficient Synthesis and Biological Evaluation of a Novel Series of 1,5-Benzodiazepine Derivatives as Potential Antimicrobial Agents","volume":"88","author":"An","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2021.105331_b0175","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1039\/C5OB00655D","article-title":"1, 5-Benzodiazepine derivatives as potential antimicrobial agents: design, synthesis, biological evaluation, and structure\u2013activity relationships","volume":"13","author":"Wang","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0180","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0223-5234(01)01283-1","article-title":"1,5-Benzodiazepines. Part XII. Synthesis and biological evaluation of tricyclic and tetracyclic 1,5-benzodiazepine derivatives as nevirapine analogues","volume":"36","author":"Braccio","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0185","first-page":"229","article-title":"Recent Development in [1,4]Benzodiazepines as Potent Anticancer Agents: A Review Mini-Reviews","volume":"14","author":"Gill","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0190","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.jscs.2013.10.004","article-title":"Design, synthesis and in vitro cytotoxicity study of benzodiazepine-mustard conjugates as potential brain anticancer agents","volume":"21","author":"Singh","year":"2017","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105331_b0195","first-page":"345","article-title":"1, 5-Benzodiazepine: A versatile pharmacophore","volume":"4","author":"Salve","year":"2013","journal-title":"Int. J. Pharm. Bio. Sci."},{"key":"10.1016\/j.bioorg.2021.105331_b0200","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/00397910802372517","article-title":"Tauda; Maturana R; Sicker D, Synthesis of 1, 5-benzodiazepines with unusual substitution pattern from chalcones under solvent-free microwave irradiation conditions","volume":"39","author":"Escobar","year":"2008","journal-title":"Syn. Comm."},{"key":"10.1016\/j.bioorg.2021.105331_b0205","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/cjoc.200890213","article-title":"An Efficient Synthesis of 1,5-Benzodiazepine Derivatives by Lanthanide Trichloride-catalyzed Condensation of o-Phenylenediamine with \u03b1, \u03b2-Unsaturated Ketone under Mild Conditions","volume":"26","author":"Feng","year":"2008","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0210","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/00397910500383527","article-title":"Efficient Synthesis of 1,5-Benzodiazepine Derivatives by Ytterbium Trichloride-Catalyzed Condensation of o-Phenylenediamine and Ketones","volume":"36","author":"Wu","year":"2006","journal-title":"Syn. Comm."},{"key":"10.1016\/j.bioorg.2021.105331_b0215","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1246\/cl.130580","article-title":"One-pot Synthesis of 2, 3-Benzodiazepines from Arynes and \u03b2-Diketones","volume":"42","author":"Okuma","year":"2013","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105331_b0220","doi-asserted-by":"crossref","first-page":"19300","DOI":"10.1039\/c3ra42283f","article-title":"Synthesis, characterization, antimicrobial, anticancer, and antituberculosis activity of some new pyrazole, isoxazole, pyrimidine and benzodiazepine derivatives containing thiochromeno and benzothiepino moieties","volume":"3","author":"Palanisamy","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2021.105331_b0225","first-page":"2017","article-title":"Asymmetric Hydrogenation of Cyclic Imines of Benzoazepines and Benzodiazepines with Chiral, Cationic Ruthenium-Diamine Catalysts","volume":"2017","author":"Yang","year":"1973","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0230","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/chem.201604561","article-title":"One-Pot Procedure for the Synthesis of 1,5-Benzodiazepines from N-Allyl-2-bromoanilines","volume":"23","author":"Weers","year":"2017","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2021.105331_b0235","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1021\/acs.orglett.6b01720","article-title":"Construction of the 1,5-Benzodiazepine Skeleton from o-Phenylendiamine and Propargylic Alcohols via a Domino Gold-Catalyzed Hydroamination\/Cyclization Process","volume":"18","author":"Cacchi","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2021.105331_b0240","first-page":"67","article-title":"Titanium-Catalyzed Hydroaminoalkylation of Vinylsilanes and a One-Pot Procedure for the Synthesis of 1,4-Benzoazasilines","volume":"6","author":"Chari","year":"2005","journal-title":"Cat. Comm."},{"key":"10.1016\/j.bioorg.2021.105331_b0245","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00706-014-1275-9","article-title":"FeCl3\u2013SiO2 promoted one-pot, three-component synthesis of novel 1,5-benzodiazepine derivatives","volume":"146","author":"An","year":"2015","journal-title":"Monatsh Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0250","first-page":"5215","article-title":"Enhanced Catalytic Properties of Carbon supported Zirconia and Sulfated Zirconia for the Green Synthesis of Benzodiazepines","volume":"10","author":"GodinoL","year":"2018","journal-title":"Chem. Cat. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0255","first-page":"1711","article-title":"An Efficient and Green Protocol for the Synthesis of 1,5-benzodiazepine and Quinoxaline Derivatives Using Protic Pyridinium Ionic Liquid as a Catalyst","volume":"22","author":"Alinezhad","year":"2013","journal-title":"World Appl. Sci. J."},{"key":"10.1016\/j.bioorg.2021.105331_b0260","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10562-019-02668-z","article-title":"Preparation and Application of a New Supported Nicotine-Based Organocatalyst for Synthesis of Various 1, 5-Benzodiazepines","volume":"149","author":"Korbekandi","year":"2019","journal-title":"Cat. Lett."},{"key":"10.1016\/j.bioorg.2021.105331_b0265","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3923\/jpt.2006.573.578","article-title":"An expeditious synthesis of 1, 5-benzodiazepine derivatives catalysed by p-toluenesulfonic acid","volume":"1","author":"Pasha","year":"2006","journal-title":"J. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioorg.2021.105331_b0270","first-page":"101","article-title":"khan A, Citric Acid-catalyzed Solvent Free, an Efficient One-pot Synthesis of 2, 3-Dihydro-1H-1, 5-Benzodiazepine Derivatives","volume":"3","author":"Baseer","year":"2011","journal-title":"Recent Res. Sci. Technol."},{"key":"10.1016\/j.bioorg.2021.105331_b0275","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1081\/SCC-200034752","article-title":"[(L)Proline]2Zn Catalysed Synthesis of 1,5-Benzodiazepine Derivatives Under Solvent-Free Condition","volume":"34","author":"Sivamurugan","year":"2004","journal-title":"Syn. Comm."},{"key":"10.1016\/j.bioorg.2021.105331_b0280","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1016\/j.tetlet.2016.11.089","article-title":"Chemo-\/regio-selective synthesis of 2-aryl-3-acetyl-2, 4-dihydro-1H-5H-1, 5-benzodiazepines using Lewis acid, CeCl3\u00b7 7H2O","volume":"57","author":"Yin","year":"2016","journal-title":"Tet. Lett."},{"key":"10.1016\/j.bioorg.2021.105331_b0285","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1039\/C6GC01279E","article-title":"A decade update on solvent and catalyst-free neat organic reactions: a step forward towards sustainability","volume":"18","author":"Majee","year":"2016","journal-title":"Green Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0290","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12039-012-0345-y","article-title":"Thiamine hydrochloride: An efficient catalyst for one-pot synthesis of quinoxaline derivatives at ambient temperature","volume":"125","author":"Pawar","year":"2013","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.bioorg.2021.105331_b0295","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1007\/s11164-016-2843-x","article-title":"Cheap thiamine hydrochloride as efficient catalyst for synthesis of 4H-benzo[b]pyrans in aqueous ethanol","volume":"43","author":"Chen","year":"2017","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bioorg.2021.105331_b0300","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1016\/j.tetlet.2009.08.081","article-title":"Thiamine hydrochloride as a efficient catalyst for the synthesis of amidoalkyl naphthols","volume":"50","author":"Lei","year":"2009","journal-title":"Tet. Lett."},{"key":"10.1016\/j.bioorg.2021.105331_b0305","first-page":"41","article-title":"Thiamine Hydrochloride-Catalyzed One-Pot Synthesis of 1, 4-Dihydropyridine Derivatives Under Solvent-Free Conditions","volume":"2011","author":"Lei","year":"1969","journal-title":"Syn. Comm."},{"key":"10.1016\/j.bioorg.2021.105331_b0310","first-page":"1","article-title":"A Review on the medicinal importance of pyridine derivatives","volume":"1","author":"Altaf","year":"2015","journal-title":"J. Drug Des. Medicinal Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0315","doi-asserted-by":"crossref","first-page":"42998","DOI":"10.1039\/D0RA08526J","article-title":"Synthesis of novel naphthalene-heterocycle hybrids with potent antitumor, anti-inflammatory and antituberculosis activities","volume":"10","author":"Abozeid","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2021.105331_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104141","article-title":"Design, synthesis, molecular modeling, and biological evaluation of pyrazole-naphthalene derivatives as potential anticancer agents on MCF-7 breast cancer cells by inhibiting tubulin polymerization","volume":"103","author":"Wang","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105331_b0325","first-page":"C74","article-title":"Synthesis, crystal, structure and biological properties of a cis-dichloridobis(diimine)copper(II) complex","author":"Bhat","year":"2018","journal-title":"Acta Cryst."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821007082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821007082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:23:42Z","timestamp":1758615822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821007082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":65,"alternative-id":["S0045206821007082"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105331","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of elementary derivatives of 1,5-benzodiazepine as anticancer agents with synergy potential","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105331"}}